Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001529
Filing Date
2021-08-19
Accepted
2021-08-19 16:19:54
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgo-20210630.htm   iXBRL 10-Q 2404807
2 EX-31.1 imgo-20210630ex31_1.htm EX-31.1 28207
3 EX-31.2 imgo-20210630ex31_2.htm EX-31.2 28088
4 EX-32.1 imgo-20210630ex32_1.htm EX-32.1 18543
  Complete submission text file 0000950170-21-001529.txt   7596218

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgo-20210630_cal.xml EX-101.CAL 35227
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20210630_lab.xml EX-101.LAB 336577
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20210630.xsd EX-101.SCH 37096
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20210630_pre.xml EX-101.PRE 265092
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgo-20210630_def.xml EX-101.DEF 159839
10 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20210630_htm.xml XML 1405810
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
Type: 10-Q | Act: 34 | File No.: 001-40604 | Film No.: 211190303
SIC: 2834 Pharmaceutical Preparations